Polycystic Ovary Syndrome-Is the Cardiometabolic Risk Increased After Menopause?

被引：0
|
作者：
Dokras, Anuja [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2017年 / 24卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：1421 / 1422
页数：2
相关论文
共 50 条
  • [31] A Unique Rodent Model of Cardiometabolic Risk Associated with the Metabolic Syndrome and Polycystic Ovary Syndrome
    Shi, Danni
    Dyck, Michael K.
    Uwiera, Richard R. E.
    Russell, Jim C.
    Proctor, Spencer D.
    Vine, Donna F.
    ENDOCRINOLOGY, 2009, 150 (09) : 4425 - 4436
  • [32] Impact of Lisinopril on Cardiometabolic Risk Factors in Sisters of Women With Polycystic Ovary Syndrome
    Krysiak, Robert
    Kowalcze, Karolina
    Okopien, Boguslaw
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (09): : 1045 - 1052
  • [33] The Impact of Atorvastatin on Cardiometabolic Risk Factors in Sisters of Women with Polycystic Ovary Syndrome
    Krysiak, Robert
    Kowalcze, Karolina
    Okopien, Boguslaw
    PHARMACOLOGY, 2023, 108 (05) : 451 - 459
  • [34] The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
    Robert Krysiak
    Witold Szkróbka
    Bogusław Okopień
    Pharmacological Reports, 2021, 73 : 261 - 268
  • [35] Serum visfatin as predictive marker of cardiometabolic risk in women with polycystic ovary syndrome
    Rashad, Nearmeen M.
    Abd-Elrahman, M. N. Ayman
    El-Shal, Amal S.
    Amin, Abdelaziz I.
    MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2018, 23 (04) : 335 - 341
  • [36] Women with polycystic ovary syndrome are at increased risk of postnatal depression
    Davies, M.
    March, W.
    Whitrow, M.
    Fernandez, R.
    Moore, V.
    HUMAN REPRODUCTION, 2018, 33 : 322 - 322
  • [37] Does body weight affect cardiometabolic risk in women with polycystic ovary syndrome?
    Dokras, Anuja
    FERTILITY AND STERILITY, 2019, 111 (01) : 56 - 57
  • [38] Increased risk of depression in women with polycystic ovary syndrome.
    Hollinrake, EM
    Abreu, A
    Sparks, A
    Van Voorhis, B
    Dokras, A
    FERTILITY AND STERILITY, 2005, 84 : S55 - S55
  • [39] Antimullerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome
    Feldman, Rebecca A.
    O'Neill, Kathleen
    Butts, Samantha F.
    Dokras, Anuja
    FERTILITY AND STERILITY, 2017, 107 (01) : 276 - 281
  • [40] Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome
    Harmanci, Ayla
    Cinar, Nese
    Bayraktar, Miyase
    Yildiz, Bulent Okan
    CLINICAL ENDOCRINOLOGY, 2013, 78 (01) : 120 - 125
12345